Vitrolife has entered into a two year collaboration agreement with University of Melbourne regarding collaboration with the stem cells expertise of the development of clinical grade stem cell media.
“University of Melbourne has a unique expertise within stem cells, above all in the field of pluripotent stem cells and as such is a valuable resource in developing the right products for a rapidly growing market”
"The regenerative medicine area is rapidly growing both within industry and academia. There is today an unmet need of high quality clinical grade stem cell media", says Magnus Nilsson, Vitrolife's CEO.
"University of Melbourne has a unique expertise within stem cells, above all in the field of pluripotent stem cells and as such is a valuable resource in developing the right products for a rapidly growing market", says Anna Mårtensson, Head of Stem Cell business area at Vitrolife.
Fluidic Sciences acquires business and assets of Sphere Bio to accelerate single-cell and protein interaction discovery